Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001837 |
---|---|
Receipt number | R000002140 |
Scientific Title | A PhaseII trial of oral etopocide and iv irinotecan for patients with platinum resistant and taxane pretreated ovarian cancer(JCOG0503) |
Date of disclosure of the study information | 2009/04/01 |
Last modified on | 2014/12/04 17:56:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/04/01 13:34:15 | ||
2 | Update | 2009/10/09 15:48:46 | Name of person sending information Name of person sending information |
|
3 | Update | 2010/06/04 15:44:48 | Institutions |
|
4 | Update | 2010/06/04 15:45:18 | Recruitment status |
|
5 | Update | 2010/10/05 18:33:30 | Recruitment status |
|
6 | Update | 2010/12/09 18:08:45 | Recruitment status |
|
7 | Update | 2012/06/20 11:41:08 | Acronym Acronym |
|
8 | Update | 2013/03/26 17:03:09 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
9 | Update | 2013/04/09 11:23:51 | Recruitment status Last follow-up date |
|
10 | Update | 2013/07/09 14:55:51 | Institutions |
|
11 | Update | 2014/06/03 14:39:40 | Recruitment status |
|
12 | Update | 2014/12/04 17:56:52 | Publication of results URL related to results and publications Results Results |